Diagnosis, treatment, and prognosis of glioma: Five new things

Neurology

Volumn 75, Issue 18 SUPPL.1, 2010, Pages

  Taylor, Lynne P ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; ETIRACETAM; PHENOBARBITAL; PHENYTOIN; TEMOZOLOMIDE;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DRUG EFFECT; DRUG HALF LIFE; EPILEPSY; GLIOBLASTOMA; GLIOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE;

BRAIN NEOPLASMS; GLIOMA; HUMANS; PROGNOSIS; QUALITY OF LIFE;

EID: 78650156695     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181fb3661     Document Type: Article

References (13)

1. Christakis NA. Death foretold: prophecy and prognosis in medical care. Chicago: University of Chicago Press; 1999.
2. Van Mier EG, Hadjipanayis CG, Norden AD, Shu H-K, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 2010;60:166-193.
3. Gadji M, Fortin D, Tsanaclis A-M, Drouin R. Is the 1P-19Q deletion a diagnostic marker of oligodendrogliomas? Cancer Genet Cytogenet 2009;194:12-22.
4. Mehdiratta M, Selim M. Value of perfusion computed tomography in stroke mimics. Arch Neurol 2007;64:1348-1349.
5. Bower RS, Burrus TM, Giannini C, et al. Teaching Neu-roImages: Demyelinating disease mimicking butterfly high-grade glioma. Neurology 2010;75;e4-e5.
6. Rio M, Lebre AS, de Lonlay P, et al. NeuroImages: Mito-chondrial ND5 mutations mimicking brainstem tectal gli-oma. Neurology 2010;75:93.
7. Gestner ER, Frosch MP, Batchelor TT. Diffusion magnetic resonance imaging detects pathologically confirmed, non-enhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab. JCO 2010;28: e91-e93.
8. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008;9:453-461.
9. Ruggiero A, Rizzo D, Mastrangelo S, Battaglia D, Attina G, Riccardi R. Interactions between antiepileptic and che-motherapeutic drugs in children with brain tumors: is it time to change treatment? Pediatr Blood Cancer 2010;54: 193-198.
10. Bobustuc GC, Baker CH, Limaye A, et al. Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro-Oncology 2010;1-11.
11. Sizoo EM, Braam L, Postma TJ, et al. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro-Oncology Epub 2010 Jan 27.
12. Pace A, DiLorenzo C, Guariglia L, Jandolo B, Carapella CM, Pompili A. End of life issues in brain tumor patients. J Neurooncol 2009;91:39-43.
13. Liu R, Page M, Solheim K, Fox S, Chang SM. Quality of life in adults with brain tumors: Current knowledge and future directions. Neuro-Oncology 2009;11:330-339.